Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1995-06-01
1998-11-03
Marx, Irene
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
424 9463, 435212, 435214, 435215, 435216, 530380, 530381, 514822, 514834, A61K 3848, C12N 948, C12N 970, C12N 972
Patent
active
058304673
ABSTRACT:
A pharmaceutical preparation contains protein C and a thrombolytically active substance that does not activate protein C. This preparation prevents reocclusion usually occurring in the course of thrombolysis therapy.
REFERENCES:
patent: 5084274 (1992-01-01), Griffin et al.
Kohler et al., "Coninuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity," Nature, vol. 256, pp. 495-497 (Aug. 1975).
Stassen et al., "Thrombolysis with Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits with Experimental Jugular Vein Thrombosis," J. Clin, Invest., vol. 71, pp. 368-376 (Feb. 1983).
Gruber et al., "Inhibition of Thrombus Formation by Infusion of Activated Protein C with Urokinase in a Primate Thrombosis Model," Blood, vol. 74, No. 7, Suppl. 1, Abstract No. 176 (Nov. 1989).
Yang et al., "Plasminogen, Alpha.sub.2 -antiplasmin, and Protein C Decline Following Infusions of Recombinanat Tissue Plaminogen Activator," Seminars in Thrombosis and Hemostasis, vol. 16, No. 3, pp. 242-244 (1990).
Gulba et al., "Increased Thrombin Levels During Thrombolytic Therapy in Acute Myocardial Infarction," Circulation, vol. 83, No. 3, pp. 937-944 (Mar. 1991).
Eisenberg et al., "Differential Effects of Activation of Prothrombin by Streptokinase compared With Urokinase and Tissue-Type Plasminogen Activator", Thrombosis Research, vol. 50:707-717, (1988).
Okajima et al., "Effect of Protein C and Activated Protein C on Coagulation and Fibrinolysis in Normal Human Subjects", Thrombosis and Haemostasis, vol. 63:48-53, (1990).
Vukovich et al., Replacement Therapy for a Homozygous Protein C Deficiency-State using a Concentrate of Human Protein C and S, British Journal of Haematology, vol. 70, 435-440, 1988.
Sigma Catalog, Sigma Chemical Company, p. 853, 1990.
Seligsohn et al., Homozygous Protein C Deficiency Manifested By Venous Thrombosis in the Newborn. N Engl. J. Med, 310:559-562, 1984.
Juhan-Vague et al., Plasma Levels of a Specific Inhibitor of Tissue-Type Plasminogen Activator (and Urokinase) in Normal and Pathological Conditions. Thromb. Res. 33:523-530, 1984.
Eibl Johann
Philapitsch Anton
Schwarz Hans Peter
Immuno Aktiengesellschaft
Kerr Janet M.
Marx Irene
LandOfFree
Pharmaceutical preparation containing protein C and a thrombolyt does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical preparation containing protein C and a thrombolyt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical preparation containing protein C and a thrombolyt will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-686706